Stock Report

Download full stock data and analysis for free Last Updated: 02-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Ajanta Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: AJANTPHARM | BSE: 532331

₹3,396.30

up-down-arrow ₹-112.50 (-3.21%)

As on 02-Nov-2026IST

Market cap

info icon

₹42,419 Cr

Revenue (TTM)

info icon

₹6,217 Cr

P/E Ratio

info icon

33.6

P/B Ratio

info icon

8.7

Div. Yield

info icon

0.8 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 10.34 32.53 25.01 16.78 14.65
EBIT 31.90 75.52 32.42 26.29 11.80
Net Profit 16.13 49.18 29.70 24.13 12.35
EPS 16.13 49.18 29.70 24.61 13.24
Book Value -- -- 19.52 10.41 9.43
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 23.5822.5124.2222.4024.00
Net Margin info 19.7118.6219.7018.7719.41
Return on equity info 24.8422.8826.9125.4225.06
Return on Capital info 32.7529.94--32.6732.87
Return on Assets info 19.0217.1620.8818.5919.13
Debt to Equity (x) info ----0.000.050.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
32.67
32.87
32.22
22.57
Peer Median
--
19.41
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

26.91

Higher than Peers by 11.74

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
26.91
25.42
25.06
23.49
17.68
Peer Median
15.17
18.29
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

20.88

Higher than Peers by 10.78

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
20.88
18.59
19.13
17.73
13.21
Peer Median
10.10
9.88
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

24.22

Higher than Peers by 5.72

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
24.22
22.40
24.00
24.63
17.43
Peer Median
18.50
19.35
18.93
21.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

19.70

Higher than Peers by 5.37

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
19.70
18.77
19.41
19.01
15.31
Peer Median
14.32
13.32
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
10.88
11.96
11.93
10.03
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

25.01

Higher than Peers by 12.88

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
25.01
17.31
10.44
12.45
12.02
Peer Median
12.13
13.36
10.90
13.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

32.42

Higher than Peers by 10.70

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
32.42
9.53
7.61
58.87
-18.85
Peer Median
21.72
18.45
15.01
23.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

29.70

Higher than Peers by 6.77

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
29.70
14.73
12.77
38.81
-17.50
Peer Median
22.93
18.73
14.80
30.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

29.70

Higher than Peers by 8.30

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
29.70
14.73
13.67
38.81
-16.06
Peer Median
21.40
14.40
14.27
29.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
19.52
6.27
5.14
3.79
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
0.05
0.00
0.00
0.00
Peer Median
0.00
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
0.05
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.85

Higher than Peers by 0.83

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
2.85
2.38
2.43
3.04
2.48
Peer Median
2.02
1.90
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.13

Higher than Peers by 0.64

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
2.13
1.82
1.73
2.12
1.77
Peer Median
1.49
1.45
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

132.03

Higher than Peers by 113.00

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
132.03
86.52
58.36
155.50
128.61
Peer Median
19.03
19.02
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

29.98

Higher than Peers by 8.31

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
29.98
34.00
25.45
29.63
28.24
Peer Median
21.67
19.89
21.77
20.10
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.03

Higher than Peers by 0.32

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
1.03
1.99
1.85
1.73
1.61
Peer Median
0.71
0.74
0.76
0.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
49.07
49.80
52.69
52.87
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
29.77
35.51
37.60
40.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
183.00
187.66
183.71
157.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
--
-104.16
-102.34
-93.41
-63.66
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

33.59

Lower than Peers by 3.75

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
33.59
33.16
35.53
34.52
25.89
Peer Median
37.34
34.76
26.81
39.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

8.73

Higher than Peers by 3.95

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
8.73
7.74
8.64
7.91
4.49
Peer Median
4.78
4.93
4.65
6.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.82

Higher than Peers by 0.31

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
0.82
1.00
1.07
2.28
0.58
Peer Median
0.52
0.52
0.61
0.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

22.55

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
22.55
22.42
24.03
22.32
16.89
Peer Median
--
25.26
27.02
34.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

42,419

Higher than Peers by 24,748

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Ajanta Pharma
42,419
35,016
32,705
28,178
15,221
Peer Median
17,672
16,867
20,914
25,297
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds